TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 151 filers reported holding TRAVERE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $92,523,005 | +69.2% | 4,113,962 | +58.2% | 0.21% | +58.8% |
| Q4 2022 | $54,678,000 | -5.6% | 2,600,000 | +10.6% | 0.13% | -9.0% |
| Q3 2022 | $57,904,000 | +22.6% | 2,350,000 | +20.5% | 0.14% | +33.3% |
| Q2 2022 | $47,249,000 | +22.0% | 1,950,000 | +29.8% | 0.11% | +45.9% |
| Q1 2022 | $38,719,000 | -4.2% | 1,502,492 | +15.4% | 0.07% | +1.4% |
| Q4 2021 | $40,429,000 | -1.9% | 1,302,492 | -23.4% | 0.07% | -9.9% |
| Q3 2021 | $41,225,000 | -21.4% | 1,700,000 | -52.7% | 0.08% | -21.4% |
| Q2 2021 | $52,433,000 | -53.8% | 3,593,763 | -21.0% | 0.10% | -55.6% |
| Q1 2021 | $113,614,000 | +46.3% | 4,550,000 | +59.6% | 0.23% | +37.3% |
| Q4 2020 | $77,677,000 | – | 2,850,000 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 895,821 | $8,008,640 | 3.99% |
| Deep Track Capital, LP | 7,370,000 | $65,887,800 | 2.54% |
| VR Adviser, LLC | 2,623,677 | $23,455,672 | 2.47% |
| Sio Capital Management, LLC | 884,770 | $7,909,844 | 2.45% |
| Kynam Capital Management, LP | 957,502 | $8,560,068 | 1.40% |
| MPM BioImpact LLC | 552,846 | $4,942,443 | 1.32% |
| ARMISTICE CAPITAL, LLC | 7,500,000 | $67,050,000 | 1.03% |
| Parkman Healthcare Partners LLC | 577,494 | $5,162,796 | 0.95% |
| Tri Locum Partners LP | 251,702 | $2,250,216 | 0.72% |
| Cheyne Capital Management (UK) LLP | 26,200 | $234,228 | 0.68% |